ask="N/A"
ask_size="N/A"
average_daily_volume="1301260"
bid="N/A"
bid_size="N/A"
book_value="-0.1530"
change="-0.0020"
change_from_200_day_moving_average="-0.0310"
change_from_50_day_moving_average="0.0313"
change_from_52_week_high="-1.1375"
change_From_52_week_low="0.2745"
change_in_percent="-0.4306%"
close="0.4625"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6540"
ebitda="-18.11M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="-0.0900"
eps_estimate_next_year="-0.4500"
ex_dividend_date="N/A"
float_shares="48793000"
high="0.4800"
high_52_weeks="1.6000"
last_trade_date="2/10/2017"
last_trade_price="0.4625"
last_trade_size="1680"
last_trade_time="4:02pm"
low="0.4438"
low_52_weeks="0.1880"
market_capitalization="31.32M"
moving_average_200_day="0.4935"
moving_average_50_day="0.4312"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.0000"
open="0.4664"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-6.2796%"
percent_change_from_50_day_moving_average="+7.2633%"
percent_change_from_52_week_high="-71.0938%"
percent_change_from_52_week_low="+146.0107%"
previous_close="0.4645"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="262.1312"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="1.1600"
stock_exchange="ASE"
symbol="BPMX"
volume="649030"
weeks_range_52="0.1880 - 1.6000"
